US2016237033A1PendingUtilityA1
Process for preparing alkyl pyroglutamic acids
Assignee: DOW GLOBAL TECHNOLOGIES LLCPriority: Dec 15, 2011Filed: Feb 17, 2016Published: Aug 18, 2016
Est. expiryDec 15, 2031(~5.4 yrs left)· nominal 20-yr term from priority
C11D 3/28A61K 8/44C11D 3/33C11D 3/32A61Q 19/10A61K 2800/805C11D 1/10A61K 2800/49A61K 8/4913C07D 207/18B01J 2531/002A61K 2800/30C07D 207/28B01J 2231/005B01J 31/0271C07D 207/02A61Q 5/02C09K 23/02C09K 23/32
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are compounds of formulae: and salts, hydrates, or solvates thereof, where R 1 , R 2 , R 3 , R 5 , and R 6 are defined herein, compositions containing these compounds, methods of preparing these compounds, and methods of using these compounds in a variety of applications, such as a surfactant or additive in personal care products.
Claims
exact text as granted — not AI-modified1 . A compound of the formula (I):
or acceptable salts, hydrates, or solvates thereof; wherein
R 1 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 hydroxyalkyl, M + , or a polyoxyalkylene moiety having oxyalkyl groups that are the same or different, and where the polyoxyalkylene moiety is capped or uncapped;
where M + is a cation forming a salt;
R 2 and R 3 are independently C 2 -C 24 alkyl, C 2 -C 24 alkenyl, or C 2 -C 24 alkynyl, each optionally substituted with one or more of R 4 ; and
wherein R 4 is halogen, —CN, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 haloalkyl, —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl) 2 , —OH, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, —CO 2 H, —CO 2 (C 1 -C 6 alkyl), —CON(C 1 -C 6 alkyl), —CON(C 1 -C 6 alkyl) 2 , C 3 -C 8 cycoalkyl, aryl, heteroaryl, or heterocyclyl, wherein each cycloalkyl, aryl, heteroaryl, and heterocyclyl are optionally substituted with one or more of halogen, —CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, —NH 2 , —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl) 2 , —OH, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, —CO 2 H, —CO 2 (C 1 -C 6 alkyl), —CON(C 1 -C 6 alkyl), or —CON(C 1 -C 6 alkyl) 2 ;
or R 4 is polyoxyalkylene moiety having oxyalkyl groups that are the same or different, and where the polyoxyalkylene moiety is capped or uncapped.
2 . A compound according to claim 1 , wherein R 1 is hydrogen or M + .
3 . A compound according to claim 1 , wherein R 1 is a polyoxyalkylene moiety having oxyalkyl groups that are the same or different, and where the polyoxyalkylene moiety is capped or uncapped.
4 . A compound according to claim 1 , wherein R 2 is C n alkyl, and R 3 is C n-2 alkyl, each optionally substituted with one or more of R 4 , and wherein n is 4-12.
5 . A compound according to claim 4 , wherein n is 5 or 10.
6 . A compound according to claim 1 , which is:
7 . A composition comprising a compound according to claim 1 , and at least one additive, excipient or diluent.
8 . A composition comprising at least two compounds selected from the compounds of formula (II):
or acceptable salts, hydrates, or solvates thereof; wherein
R 5 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 hydroxyalkyl, M + , or a polyoxyalkylene moiety having oxyalkyl groups that are the same or different, and where the polyoxyalkylene moiety is capped or uncapped;
where M + is a cation forming a salt;
R 6 is unbranched or branched C 2 -C 24 alkyl, unbranched or branched C 2 -C 24 alkenyl, unbranched or branched C 2 -C 24 alkynyl, C 3 -C 8 cycloalkyl, or C 3 -C 8 cycloalkyl(C 1 -C 6 alkyl), each optionally substituted with one or more of R 7 , and
wherein R 7 is halogen, —CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, —NH 2 , —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl) 2 , —OH, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, —CO 2 H, —CO 2 (C 1 -C 6 alkyl), —CON(C 1 -C 6 alkyl), —CON(C 1 -C 6 alkyl) 2 , C 3 -C 8 cycloalkyl, aryl, heteroaryl, or heterocyclyl, wherein each cycloalkyl, aryl, heteroaryl, and heterocyclyl are optionally substituted with one or more of halogen, —CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, —NH 2 , —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl) 2 , —OH, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, —CO 2 H, —CO 2 (C 1 -C 6 alkyl), —CON(C 1 -C 6 alkyl),
or —CON(C 1 -C 6 alkyl) 2 , and
of formula (III):
or acceptable salts, hydrates, or solvates thereof; wherein
each R 8 is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 hydroxyalkyl, M + , or a polyoxyalkylene moiety having oxyalkyl groups that are the same or different, and where the polyoxyalkylene moiety is capped or uncapped;
where M + is a cation forming a salt;
R 9 is unbranched or branched C 2 -C 24 alkyl, unbranched or branched C 2 -C 24 alkenyl, unbranched or branched C 2 -C 24 alkynyl, O 3 —C 8 cycloalkyl, or C 3 -C 8 cycloalkyl(C 1 -C 6 alkyl), each optionally substituted with one or more of R 10 ; and
wherein R 10 is halogen, —CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, —NH 2 , —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl) 2 , —OH, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, —CO 2 H, —CO 2 (C 1 -C 6 alkyl), —CON(C 1 -C 6 alkyl), —CON(C 1 -C 6 alkyl) 2 , C 3 -C 8 cycloalkyl, aryl, heteroaryl, or heterocyclyl, wherein each cycloalkyl, aryl, heteroaryl, and heterocyclyl are optionally substituted with one or more of halogen, —CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, —NH 2 , —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl) 2 , —OH, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, —CO 2 H, —CO 2 (C 1 -C 6 alkyl), —CON(C 1 -C 6 alkyl),
or —CON(C 1 -C 6 alkyl) 2 .
9 . A composition according to claim 8 further comprising at least one additive, excipient or diluent.
10 . A composition according to claim 8 , comprising at least two compounds of formula (II).
11 . A composition according to claim 10 , comprising at least two compounds that are:
12 . A composition according to claim 12 , comprising at least two compounds that are:
13 . A compound according to claim 1 , for use as a surfactant, surface active additive, or phase transfer catalyst.
14 . A compound according to claim 1 for use in personal care formulations.
15 . A method of preparing a compound of formula (IV) or a mixture of one or more compounds of formula (IV):
or acceptable salts, hydrates, or solvates thereof; wherein
R 11 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 hydroxyalkyl, M + , or a polyoxyalkylene moiety having oxyalkyl groups that are the same or different, and can be capped or uncapped;
where M + is a cation forming a salt;
R 12 is unbranched or branched C 3 -C 24 alkyl, unbranched or branched C 3 -C 24 alkenyl, or unbranched or branched C 3 -C 24 alkynyl, each optionally substituted with one or more of R 15 ; and
wherein R 15 is halogen, —CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, —NH 2 , —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl) 2 , —OH, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, —CO 2 H, —CO 2 (C 1 -C 6 alkyl), —CON(C 1 -C 6 alkyl), —CON(C 1 -C 6 alkyl) 2 , C 3 -C 8 cycloalkyl, aryl, heteroaryl, or heterocyclyl, wherein each cycloalkyl, aryl, heteroaryl, and heterocyclyl are optionally substituted with one or more of halogen, —CN, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, —NH 2 , —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl) 2 , —OH, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, —CO 2 H, —CO 2 (C 1 -C 6 alkyl), —CON(C 1 -C 6 alkyl),
or —CON(C 1 -C 6 alkyl) 2 ;
comprising
treating a glutamate of formula:
wherein each R 14 is independently selected form hydrogen, M + , C 1 -C 6 alkyl, C 1 -C 6 hydroxyalkyl, —(C 1 -C 6 alkyl-0) 1-4 H, aryl, aryl(C 1 -C 6 alkyl), or polyoxyalkylene unit;
with an aldehyde of formula:
wherein R 13 is C 1 -C 23 alkyl, C 2 -C 23 alkenyl, or C 2 -C 23 alkynyl, each optionally substituted with one or more of R 15 .
16 . A personal care formulation comprising a compound according to claim 1 .
17 . A personal care formulation comprising a composition according to claim 7 .
18 . A method for carrying out phase transfer in a reaction system comprising adding to the system a compound according to claim 1 .
19 . A method for carrying out phase transfer in a reaction system comprising adding to the system a composition according to claim 7 .
20 . A personal care formulation according to claim 16 , where the formulation is a shampoo or a body wash formulation.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.